Yet another study has found that high co-pays could restrict cardiovascular disease patients’ access to prescription drugs.
Out-of-Pocket Costs a Barrier to CVD Patients’ Treatment
Yet another study has found that high co-pays could restrict cardiovascular disease patients’ access to prescription drugs.